81
81
Mar 1, 2012
03/12
by
CNBC
tv
eye 81
favorite 0
quote 0
here is seema mody with a look at what else is moving on the nasdaq. seema. >> that's right, mandy.oints away from hitting 3,000. it's not just apple and microsoft making big moves. let's stick with tech. look at seagate technologies. the company recapturing the lead in the hard disk drive shipments during the fourth quarter ousting western digital which has suffered heavy losses from the thai floods. that's a stock to watch. on to the best performer of the nasdaq 100. you might not know this. it's wynn resorts. gaming revenue in macau coming in by 22% for the month of february boosting investor confidence telling us casinos are performing well. year-to-date the stock is up around 11%. also look at retail stocks. they've been on a tear on the upbeat retail sales data. stock up better than 1%. not to be a debbie downer but look at research in motion. jeffrey's saying rim will most likely not compete with the popularity of the apple iphone sk. >> you probably heard matt say 13,000 on the dow becoming not psychological. what are people saying about 3,000 for the number for the nas? >>
here is seema mody with a look at what else is moving on the nasdaq. seema. >> that's right, mandy.oints away from hitting 3,000. it's not just apple and microsoft making big moves. let's stick with tech. look at seagate technologies. the company recapturing the lead in the hard disk drive shipments during the fourth quarter ousting western digital which has suffered heavy losses from the thai floods. that's a stock to watch. on to the best performer of the nasdaq 100. you might not know...
95
95
Mar 26, 2012
03/12
by
CNBC
tv
eye 95
favorite 0
quote 0
let's check in with seema mody at the nasdaq. the nasdaq at its best levels in over a decade, right? >> mandy, risk-on continues. witnessing best quarter since 1991. the nasdaq 100, the subset of stocks is turning in 12 straight weeks of gains. some money managers saying tech is still cheap and has the ability to run up even higher. when you have a risk-on rally, you naturally see investors pile into tech. interestingly enough it's not just high beta momentum names adding strength. it's the older tech stocks that are seeing some green today. keep in mind though during the last week of the month we usually see some window dressing which basically means investors are grabbing some of the quarter's best performers to dress up their portfolio listings. >> window dressing, got to love it. thank you very much, seema mody. >> all right. who says that old technology stocks are dead? some of the big boys are looking a little more magic than matlock. intel, microsoft, nasdaq 100 all up double digits this year. intel not trading at levels s
let's check in with seema mody at the nasdaq. the nasdaq at its best levels in over a decade, right? >> mandy, risk-on continues. witnessing best quarter since 1991. the nasdaq 100, the subset of stocks is turning in 12 straight weeks of gains. some money managers saying tech is still cheap and has the ability to run up even higher. when you have a risk-on rally, you naturally see investors pile into tech. interestingly enough it's not just high beta momentum names adding strength. it's...
95
95
Mar 16, 2012
03/12
by
CNBC
tv
eye 95
favorite 0
quote 0
let's bring in seema mody with the bearish case on apple. is a bearish case. >> i guess there is. sure looks like it's been a walk in the park with apple with each new product paving the way to $400, $500 and even $600 we saw yesterday. a lot saying the stock's moved too fast and due for correction. here are a couple of headwinds that could weigh on shares of apple. wall street analysts have new expectations for the new ipad. if targets do not meet estimates, sentiment could return. and hudson square saying lines are shorter than for the launch of ipad 2. interesting. a glitch or problem when using the ipad could shake investors and customers. also the wow factor. perhaps saying it's more of an ipad 2s and doesn't have enough qualifiers to make it a 3. and if there is overwhelming demand for the ipad, any disruption with the suppliers in china could frustrate customers. so what happens if apple sells off? how would it impact the markets? well, the technology sector this year is up 19% with apple. without apple, 14%. with apple, without apple
let's bring in seema mody with the bearish case on apple. is a bearish case. >> i guess there is. sure looks like it's been a walk in the park with apple with each new product paving the way to $400, $500 and even $600 we saw yesterday. a lot saying the stock's moved too fast and due for correction. here are a couple of headwinds that could weigh on shares of apple. wall street analysts have new expectations for the new ipad. if targets do not meet estimates, sentiment could return. and...
125
125
Mar 15, 2012
03/12
by
CNBC
tv
eye 125
favorite 0
quote 0
i'm seema mody at the realtime exchange. jobless claims match a four-year low, inflation tame, and mixed data on the manufacturing front. here is where we stand right now. a big number on the s&p 500, breaking 1,400. the first time since 2008. take a look at the dow trading higher by 40 points. and the nasdaq above 3,000. the pulse of the markets, oil reacting to conflicting reports that the u.s. and britain will release emergency stocks of crude. sharon will have more of that in just a minute. the dollar giving up some of yesterday's gains. and the yield on the 10-year coming off overnight highs yield of 2.27%. our midday movers for today, let's start with advanced microdevices. moving higher on an upgrade from jaffray. take a look at csx, up better than 7% moving higher on bullish comments from their cfo conference. and then a look at guess. getting hit hard. q-4 earnings fell. and guess is pointing to weak results in europe. tyler. >> seema, thank you very much. let's get to the market action. there is action today aplent
i'm seema mody at the realtime exchange. jobless claims match a four-year low, inflation tame, and mixed data on the manufacturing front. here is where we stand right now. a big number on the s&p 500, breaking 1,400. the first time since 2008. take a look at the dow trading higher by 40 points. and the nasdaq above 3,000. the pulse of the markets, oil reacting to conflicting reports that the u.s. and britain will release emergency stocks of crude. sharon will have more of that in just a...
272
272
Mar 14, 2012
03/12
by
CNBC
tv
eye 272
favorite 0
quote 0
. >> the movers and shakers, for the averages, seema mody with that angle. >> about less than an hour left in the trading day. investors are running the numbers. relief about largely positive bank stress tests and upbeat economic data spilled over from the prior session. but investors seem to be booking profits. we have the s&p 500 and nasdaq trading in negative territory. take a look at the ten-year note, treasury prices extending their losses, pushing yields to their highest levels since october. focusing in on those bank street tests, that has been the topic of discussion. all failed to meet at least one of the capital requirements under the stress test. take a look how the stocks are faring. all in negative territory except suntrust, up 3.9%. in tech, big moves in apple. the best performer on the nasdaq 100. morgan stanley raising its price target. the stock right now up 3%. given the outperformance of apple, some are saying we should label this as its own asset class. s&p tech sector is up 18.6% year-to-date. however, without apple, it's only up 13.7%. just goes to show how much
. >> the movers and shakers, for the averages, seema mody with that angle. >> about less than an hour left in the trading day. investors are running the numbers. relief about largely positive bank stress tests and upbeat economic data spilled over from the prior session. but investors seem to be booking profits. we have the s&p 500 and nasdaq trading in negative territory. take a look at the ten-year note, treasury prices extending their losses, pushing yields to their highest...
227
227
Mar 16, 2012
03/12
by
CNBC
tv
eye 227
favorite 0
quote 0
seema mody? >> it's hard to believe that not everyone's a bull around this stock. it's up 45% year-to-date. analysts can't keep up with the run-up in the stock. just in the last two weeks, we had jeffries increasing their price target to $699. bernstein to $710. and $720 for morgan stanley. reiterating the street's confidence in apple's ability to move even higher, and continue this full force domination in the mobile and tablet world. but then there's always a but. some angry birds out there say apple's doom is not far away. here are the headwinds that could potentially weigh on shares of apple. disappointing, subpar sales of the new ipad, some kind of glitch or error found in the new tablet. not having a wow factor. some blogs writing that this is more of an ipad 2 s and doesn't have enough qualifying factors to make it a 3. lastly, any issues with the supply chain could frustrate customers. obviously. let's dig into one of those points. one of our market editors received a note about the extensive journey over pre-ordered ipad. take a look at this map. it's manu
seema mody? >> it's hard to believe that not everyone's a bull around this stock. it's up 45% year-to-date. analysts can't keep up with the run-up in the stock. just in the last two weeks, we had jeffries increasing their price target to $699. bernstein to $710. and $720 for morgan stanley. reiterating the street's confidence in apple's ability to move even higher, and continue this full force domination in the mobile and tablet world. but then there's always a but. some angry birds out...
123
123
Mar 29, 2012
03/12
by
CNBC
tv
eye 123
favorite 0
quote 0
seema mody is at the cnbc realtime exchange with all the details. seema. >> tyler, that's right.appings up a two-day panel to discuss whether heart safety studies should be required for obesity drugs. the main stock impacted by this news is vivus. in late february hit an all-time high when the fda advisory panel voted 20 to 2 in favor of the slimming drug named. optimism rose that obesity drugs could receive a favorable decision from the fda. there's two main results that could emerge from this fda meeting. if the panel says the tests can come afterdrug approval, that's good news for the fat busters. if a panel recommends testing before the drugs are approved, we could see a major selloff in shares of anti-obesity drug makers. >> if the fda rules that vivus has to run pre-approval heart trial, which would be a very negative event for vivus and see shares trade down as much as 50%. >> similar to the analyst wells fargo and jefferies also ious saying shares could lose some air. the main risk factor being of course delay to drug approval. bottom line, obesity is a growing epidemic e
seema mody is at the cnbc realtime exchange with all the details. seema. >> tyler, that's right.appings up a two-day panel to discuss whether heart safety studies should be required for obesity drugs. the main stock impacted by this news is vivus. in late february hit an all-time high when the fda advisory panel voted 20 to 2 in favor of the slimming drug named. optimism rose that obesity drugs could receive a favorable decision from the fda. there's two main results that could emerge...
275
275
Mar 29, 2012
03/12
by
CNBC
tv
eye 275
favorite 0
quote 0
seema mody is here. >> best buy currently has over 1,000 stores here in the united states. the company does plan to open around 100 mobile small and stand-alone stores in an effort to contain costs. the stock down better than 7%. whole goods downgraded to neutral. the number is unchanged but they see better opportunities elsewhere. stock down 3.4%. and deal or no deal, that continues to be the question with illumina to $6.7 billion or $51 per share. that's up by 15%. but illumina slamming the door better than 4%. telecom is in focus. we have r.w. buribaird and the for additional spectrum. one sector that continues to outperform, the health payer index, several hmo components fueling this rally. some analysts feel the supreme court may strike down obamacare. if we have a look at vivas, i want to look at that stock. some of my sources telling me that the fda will not ask them to include a heart safety trial. because of that, you can see the spike up. i'll get back to you with more details once they are confirmed. bill? >> a lot of activity in health care and bio activity. hel
seema mody is here. >> best buy currently has over 1,000 stores here in the united states. the company does plan to open around 100 mobile small and stand-alone stores in an effort to contain costs. the stock down better than 7%. whole goods downgraded to neutral. the number is unchanged but they see better opportunities elsewhere. stock down 3.4%. and deal or no deal, that continues to be the question with illumina to $6.7 billion or $51 per share. that's up by 15%. but illumina slamming...
232
232
Mar 29, 2012
03/12
by
CNBC
tv
eye 232
favorite 0
quote 0
i'm seema mody. the fda meeting that was taking place yesterday as well as today to really monitor obesity drugmakers and see if they should include an extra hard trial, hard safety trial as part of a their drug development and launch. news that we got in today, a vast majority went through a two-stage approach, pre and post. weight loss makers should consider the heart makers of that risk even when signs point to no cardiovascular harm. many times they follow what they say. humexa, at one point we were saying around 3:30 p.m. that this drug would not be impacted, that they would still be able to launch on april 17th. sources saying that still what the fda -- what the advisory panel told the fda does not apply but we're still unsure there. a lot of speculation. maria? >> seema, thank you very much. we have breaking news on r.i.m.m. the company missed estimates both on revenue and earnings. the company reporting a fourth quarter profit of 80 cents a share. the estimate called for a profit of 81 cents
i'm seema mody. the fda meeting that was taking place yesterday as well as today to really monitor obesity drugmakers and see if they should include an extra hard trial, hard safety trial as part of a their drug development and launch. news that we got in today, a vast majority went through a two-stage approach, pre and post. weight loss makers should consider the heart makers of that risk even when signs point to no cardiovascular harm. many times they follow what they say. humexa, at one...
211
211
Mar 28, 2012
03/12
by
CNBC
tv
eye 211
favorite 0
quote 0
i'm seema mody.e and guidance below expectations citing weakness. this comes after reporting a 77% drop in first-quarter profit on weaker sales and acquisition costs. applied materials in its core division. while the stock is down today, it's still up 15% year to date. maria? >> seema. thank you. allegan may have found another use for its best-selling botox. now the company is looking to expand the medical use of the product. allergan has requested european approval and fda approval way ahead of schedule. now we will speak to david, who is joining us from the equitable building. sir, good to have you on the program. thanks for joining us. >> nice to be with you again. >> first, let's talk about the r and d day today. what's your main message? >> well, very exciting. we unveiled new programs today which probably in their accumulation incremental 6 to $800 million in peak product sales for those products or indications. >> you filed applications with the european and regulators to sell botox for a trea
i'm seema mody.e and guidance below expectations citing weakness. this comes after reporting a 77% drop in first-quarter profit on weaker sales and acquisition costs. applied materials in its core division. while the stock is down today, it's still up 15% year to date. maria? >> seema. thank you. allegan may have found another use for its best-selling botox. now the company is looking to expand the medical use of the product. allergan has requested european approval and fda approval way...
214
214
Mar 1, 2012
03/12
by
CNBC
tv
eye 214
favorite 0
quote 0
i'm seema mody here at the nasdaq where the tech-heavy index once again tried to break the 3,000 thresholdnds sh level. apple and mi hitting all fresh time highs this morning. we also had a couple of other tech stocks also posting gains. take a look at advance microdevices, acquiring c mike crow. this takeover will heighten the processor market. maria, back over to you. >> seema, thank you. the republican presidential candidates are hitting the road ahead of the big sup tuesday primary in ten states. john harwood sat down exclusively with one of the front runners, rick santorum. he joins us from atlanta with the details. over to you, john. >> it was fascinating, rick santorum is known as a critic of american culture and morality. he declined to extend that criticism to wall street, saying capitalism encourages morality. he rejected calls from republican insiders and some on wall street that he get out of the race to avoid further damage to the republican ticket this fall, saying we're not going to make it stop, because i'm going to win. and he gently poked at his wealthy rival, mitt romney
i'm seema mody here at the nasdaq where the tech-heavy index once again tried to break the 3,000 thresholdnds sh level. apple and mi hitting all fresh time highs this morning. we also had a couple of other tech stocks also posting gains. take a look at advance microdevices, acquiring c mike crow. this takeover will heighten the processor market. maria, back over to you. >> seema, thank you. the republican presidential candidates are hitting the road ahead of the big sup tuesday primary in...
343
343
Mar 7, 2012
03/12
by
CNBC
tv
eye 343
favorite 0
quote 0
i'm seema mody here at the nasdaq. while apple might be posting negative gains -- is in negative territory, excuse me, we're still seeing the technology sector post gains. a nice recovery after yesterday's sell-off with microsoft and yahoo!. pandora, missing q-4 estimates, issuing weak guidance. that being a huge red flag for investors. two downgrades today. raymond james downgrading that stock. we also have citigroup lowering their rating to neutral from buy. maria, the stock down 22%. >> thank you so much, seema. just 20 minutes before the closing bell sounds. nasdaq on course to snap a three-day losing streak today. renewed optimism that greece's debt restructuring will go through. that certainly put a floor and strength into the market this morning. the nasdaq near the highs of the afternoon, with a gain on the session of about 26 points. nearly 1%. the cbo volatility index sliding back below 20 today. the vix was pretty active yesterday. and it was closing above 20. but volatility has slowed down. that is the firs
i'm seema mody here at the nasdaq. while apple might be posting negative gains -- is in negative territory, excuse me, we're still seeing the technology sector post gains. a nice recovery after yesterday's sell-off with microsoft and yahoo!. pandora, missing q-4 estimates, issuing weak guidance. that being a huge red flag for investors. two downgrades today. raymond james downgrading that stock. we also have citigroup lowering their rating to neutral from buy. maria, the stock down 22%....
231
231
Mar 23, 2012
03/12
by
CNBC
tv
eye 231
favorite 0
quote 0
. ♪ >>> from the nasdaq market side, i'm seema mody.orting a second fiscal quarter loss. company officials refusing to comment on reports that micron may be close to purchasing a company which recently filed for bankruptcy. zynga got a hit earlier this week today and with all that said, nasdaq managed to recover a late-day trade ending up by four points. maria? >> seema, thank you so much. it's been quite a week for global economy teas. putting investors on notice. today it was another wild one following the pullback on thursday. sharon epperson has the highlights. sharon? >> if you blinked, you might have missed it. we saw the $3 spike. there is a lot of anticipation, worry and angst over what may happen over the weekend in terms of the crisis in the middle east. the tensions between israel and iran. if you read john kilduff's piece, he points out that this is market is incredibly nervous of what could happen in terms of iran. but we did see the market able to hold on to some of those gains for the session. for the week, we looked at p
. ♪ >>> from the nasdaq market side, i'm seema mody.orting a second fiscal quarter loss. company officials refusing to comment on reports that micron may be close to purchasing a company which recently filed for bankruptcy. zynga got a hit earlier this week today and with all that said, nasdaq managed to recover a late-day trade ending up by four points. maria? >> seema, thank you so much. it's been quite a week for global economy teas. putting investors on notice. today it was...
274
274
Mar 2, 2012
03/12
by
CNBC
tv
eye 274
favorite 0
quote 0
seema mody here. technology stocks, which have been providing the leadership this week, are slipping in today's trade. perhaps seeing some profit taking. now, with all that talk around yelp, we're closely watching other recently listed talk, including zynga, which reached an all-time high today, but pulled back at 1:00 p.m. zynga's lead game designer is leaving the company to become a director at a different startup. lastly, a look at spectrum pharmaceuticals, missing street estimates. the company has a drug on the market used to treat the side effects associated with chemotherapy. bill, back over to you. >> seema, thank you very much. about 20 minutes to go. i jinxed it when i pointed out before the break, that the dow had turned positive, not only for the day, but for the week. because during the commercial break, it turned around and headed lower again. it happens every time, doesn't it? the dow now down about four points. time for a quick market stat che check. right now, the composite index is do
seema mody here. technology stocks, which have been providing the leadership this week, are slipping in today's trade. perhaps seeing some profit taking. now, with all that talk around yelp, we're closely watching other recently listed talk, including zynga, which reached an all-time high today, but pulled back at 1:00 p.m. zynga's lead game designer is leaving the company to become a director at a different startup. lastly, a look at spectrum pharmaceuticals, missing street estimates. the...
280
280
Mar 7, 2012
03/12
by
CNBC
tv
eye 280
favorite 0
quote 0
seema mody. we're less than 24 hours away from the greek debt swap deadline. will enough creditors participate in the deal. let's get to michelle caruso-cabrera, she joins me on the telephone from athens tonight with the latest. michelle? >> significant news today in athens, maria. we've learned from announcements from bond holders that at least 50%, more than 50% have said they are going to agree to the deal. the 50% is a key level for the possible imposition by the greek government of what's known as cacs. if the greek government imposes them, it will force the deal on a large number of bond holders. that means the deal is more likely to happen. it also means that they're likely to trigger credit default swaps. there's still a lot of things that could go go wrong. we don't know if we'll get too many no-votes. there's lots of permutations here. the 50% level was crossed today. we wait now to see what happens 3:00 tomorrow, about whether or not this deal is finally successful. >> so michelle, give us a sense of what happens next. you've got the big payment due
seema mody. we're less than 24 hours away from the greek debt swap deadline. will enough creditors participate in the deal. let's get to michelle caruso-cabrera, she joins me on the telephone from athens tonight with the latest. michelle? >> significant news today in athens, maria. we've learned from announcements from bond holders that at least 50%, more than 50% have said they are going to agree to the deal. the 50% is a key level for the possible imposition by the greek government of...
145
145
Mar 7, 2012
03/12
by
CNBC
tv
eye 145
favorite 0
quote 0
let's get to seema mody with the latest on that. >> it's not only about apple.'s take a look at a couple of the other big movers here. starting with ciena. the network gear maker saw margins improve and operating expenses shrink for the first quarter. that stock outperforming today. retail, we had credit suisse upgrating lululemon saying they're increasingly confident the company can sustain double-digit sales growth, raise margins and drive earnings even higher. i spoke to the analyst. interesting conversation. he says this isn't just an athletic brand, it's turning into a casual wear company. interesting perspective there. on the flip side we have to take a look at pandora. the stock falling today losing more than 1/5 of its market value as hedge fund investors sell out of the name. the street was expecting the company to beat estimates. so people piled into earnings before overlooking some of the basic issues. the stock down 24%. >> seema, thank you for that. meantime, is goodyear losing traction? that stock down more than 13% this year in what has been a pre
let's get to seema mody with the latest on that. >> it's not only about apple.'s take a look at a couple of the other big movers here. starting with ciena. the network gear maker saw margins improve and operating expenses shrink for the first quarter. that stock outperforming today. retail, we had credit suisse upgrating lululemon saying they're increasingly confident the company can sustain double-digit sales growth, raise margins and drive earnings even higher. i spoke to the analyst....
275
275
Mar 12, 2012
03/12
by
CNBC
tv
eye 275
favorite 0
quote 0
seema mody here. the nasdaq trading in negativer to but there are pockets of strength.ing the names. the top biotech pick for, reg general er ron. positive comments saying an inexpensive obesity stock with positive potential for orexigen. the company stopping a late stage clinical trial of a hard drug for an they are rah. spending time and money on a drug, taking it through clinical trials and then at the end, finding an error is risk. an they are rah down 44.8%. maria? >> seema, thank you so much. in the final stretch of trading for a monday, 15 minutes left until the closing bell sounds. a quick stat check on the dow industrials and nasdaq. composite on pace to snap a three-day winning streak today, off session lows, as you can see, the nasdaq down six points. earlier, the nasdaq down 15 points, that was the day's low, newt 29.82. cboe's volatility index touching 15.23 earlier, the loews intraday level since july 1st. the vix, as you can see, down about a point it has not settled above 20 since march 6th. bill? >>> every time the fed meets, maria, as you know, investo
seema mody here. the nasdaq trading in negativer to but there are pockets of strength.ing the names. the top biotech pick for, reg general er ron. positive comments saying an inexpensive obesity stock with positive potential for orexigen. the company stopping a late stage clinical trial of a hard drug for an they are rah. spending time and money on a drug, taking it through clinical trials and then at the end, finding an error is risk. an they are rah down 44.8%. maria? >> seema, thank...
329
329
Mar 5, 2012
03/12
by
CNBC
tv
eye 329
favorite 0
quote 0
seema mody is at the nasdaq with that angle. >> after solid gains last week, tech stocks getting hit following the broader market selloff we saw today. ongoing concerns about a slow down in china's growth. apple, of course, also weighing on the nasdaq, as we have seen before, when apple goes down, many of the component supplies also traded in negative territory. did see a selloff in chips, the semiconductor industry association announcing that global chip sales fell by 2.7% in january compared to the previous month. most of this is seasonal, a pickup in demand is what analysts are expecting for the month of february. the semiconductor index did fall one more to another pot hot spot were the tech new business, recently listed tech ipos, moving sharply to the upside and downside. pandora outperforming in trade, stifle nick, what the analyst saying pandora should benefit from the increased usable of tablets and smart phones. look at zing ga, hit by that downgrade at jpmorgan that is a look at some of the tech stocks in action today. maria, back to you. >> what is your take on apple? sup
seema mody is at the nasdaq with that angle. >> after solid gains last week, tech stocks getting hit following the broader market selloff we saw today. ongoing concerns about a slow down in china's growth. apple, of course, also weighing on the nasdaq, as we have seen before, when apple goes down, many of the component supplies also traded in negative territory. did see a selloff in chips, the semiconductor industry association announcing that global chip sales fell by 2.7% in january...
229
229
Mar 15, 2012
03/12
by
CNBC
tv
eye 229
favorite 0
quote 0
seema mody looks at where we are and how we got here. >> bill, let me tell you, it's been a long, exciting journey for apple. it all started in 2007 when apple released its first iphone. then unveiled subsequent versions, adding 3-g amid 2008, allowing customers to get faster access to the internet. and e-mail. that was right here in june 2008. then we, of course, had shares of apple then pick up steam towards the end of 2009 as we approached the unveiling of the first and only ipad, that would soon revolutionize the technology space, not only in the united states, but around the world. as you can see here, apple just continued to move to the up side, breaking $300 a share in october of 2010. just around the ipad 2 launch. slightly upgraded version of the iphone, skipping over to the end of 2011 right here, we hit $400 a share as we approached october and november. apple, though, just kept chugging along helped by upbeat earnings, strong holiday sales. in february of this year, just as news surfaced as an updated ipad would be hitting the market, apple reached $500 right here. and today, a
seema mody looks at where we are and how we got here. >> bill, let me tell you, it's been a long, exciting journey for apple. it all started in 2007 when apple released its first iphone. then unveiled subsequent versions, adding 3-g amid 2008, allowing customers to get faster access to the internet. and e-mail. that was right here in june 2008. then we, of course, had shares of apple then pick up steam towards the end of 2009 as we approached the unveiling of the first and only ipad, that...
67
67
Mar 8, 2012
03/12
by
CNBC
tv
eye 67
favorite 0
quote 0
. >> seema mody, good news there. on the cancer pill market.venge has been a fighting drug for years. >>> "street signs" rewind. robert shiller received a lot of buzz. here's what he had to say about home prices. >> in terms of housing, we might be at the end game. home prices are back to a normal level. they could just stay here. and that would be all right. right? housing is very affordable. interest rates are down, prices are down to kind of a normal level. they haven't overshot normal. maybe in terms of housing, this is it. this is it. >> so does our next guest agree, this is it? let's ask him. james camp, you had a chance to listen to professor shiller. sort of called the end game for housing, do you agree with him? >> i think we're in a bottoming process but i don't think the end game is upon us yet. the reason i say that, brian, is we still see three or four years in the visible housing space. we hf not really created a financing vehicle for residential housing post-2008. we've sort of let the general agencies limp along at the federal l
. >> seema mody, good news there. on the cancer pill market.venge has been a fighting drug for years. >>> "street signs" rewind. robert shiller received a lot of buzz. here's what he had to say about home prices. >> in terms of housing, we might be at the end game. home prices are back to a normal level. they could just stay here. and that would be all right. right? housing is very affordable. interest rates are down, prices are down to kind of a normal level....
139
139
Mar 5, 2012
03/12
by
CNBC
tv
eye 139
favorite 0
quote 0
seema mody here. technology stocks slipping in trade today. take a look at yahoo! down .5%.ngs digital reporting that the company may be looking at restructuring the company, which could lead to thousands of layoffs. we'll be sure to keep up on that story. also take a look at zynga. after hitting an all-time high on friday, today retracing those gains being hit by a jpmorgan downgrade. lastly, take a look at pandora. the stock climbing higher on a report indicating that increased popularity of tablets and smartphones will lead to improved subscriptions and profitability for pandora, the stock being the outperformer here at the nasdaq. tyler. >> seema, thank you very much. let's check in with scott wapner and see which stocks are on his radar. >> ty, i'm watching shares of apple today. i've got my screen behind me. opened at $545. traded low today as $526. we were talking a lot about this on the "fast money" "halftime report" show. the big move the stock saw just after 10:00 this morning, you can see the big dip down on the intraday chart here, there was a huge block trade as
seema mody here. technology stocks slipping in trade today. take a look at yahoo! down .5%.ngs digital reporting that the company may be looking at restructuring the company, which could lead to thousands of layoffs. we'll be sure to keep up on that story. also take a look at zynga. after hitting an all-time high on friday, today retracing those gains being hit by a jpmorgan downgrade. lastly, take a look at pandora. the stock climbing higher on a report indicating that increased popularity of...
116
116
Mar 5, 2012
03/12
by
CNBC
tv
eye 116
favorite 0
quote 0
in the meantime let's get to the nasdaq and seema mody. >> mandy, tech stocks which have been the brightt for the past couple weeks today are underperforming. three main reasons, worries about china, apple and chip stocks. let's actually start with apple. shares weighing on the nasdaq as investors get ready for that product launch on wednesday. and after closing on a high for the week, chip stocks are tumbling following that announcement that global chip sales fell 2.7% in january compared to the prior month. so we see intel down 1.8%. also advanced microdevices down 5%. lastly, it's been a mixed session for recently listed tech stocks. zynga trading lower, nose diving after jpmorgan analyst wrote that it will take some more time for zynga.com to gain traction and really materialize on the flip side though we have pandora moving higher on an upgrade. that's a stock to watch. key outperformer here at the nasdaq. mandy. >> seema, thank you for that. thousands of protesters filling the streets of moscow and st. petersburg to challenge vladimir putin's re-election victory. securing a third t
in the meantime let's get to the nasdaq and seema mody. >> mandy, tech stocks which have been the brightt for the past couple weeks today are underperforming. three main reasons, worries about china, apple and chip stocks. let's actually start with apple. shares weighing on the nasdaq as investors get ready for that product launch on wednesday. and after closing on a high for the week, chip stocks are tumbling following that announcement that global chip sales fell 2.7% in january...
276
276
Mar 15, 2012
03/12
by
CNBC
tv
eye 276
favorite 0
quote 0
seema mody has the details on that. >> hi there, bill. the milestone of the day, s&p 500 index hitting 1400. that's the first time in four years. further signs that the sufficient economy improving. job claims hitting a four-year low. green across the screen. we have the dow, nasdaq, and s&p, as i mentioned, all in positive territory. let's dig into today's top stories. financials are leading the market higher. banks across the board providing leadership in today's trade. a rebound, if you will, for some of these names. citigroup, up better than 3%. moving on, though, to some other movers, take a look at ross stores, reporting a higher profit for the holiday quarter. as shoppers sought out popular clothing brands at discount prices. that stock, though, is consolidating over the last 20 minutes. let's go now over to gas, getting hit hard. q-4 earnings disappointing the street. the company pointing to weak results in europe. that stock down better than 10%. switching over to tech, though. cisco putting its cash to use, acquiring nds for $5
seema mody has the details on that. >> hi there, bill. the milestone of the day, s&p 500 index hitting 1400. that's the first time in four years. further signs that the sufficient economy improving. job claims hitting a four-year low. green across the screen. we have the dow, nasdaq, and s&p, as i mentioned, all in positive territory. let's dig into today's top stories. financials are leading the market higher. banks across the board providing leadership in today's trade. a...
245
245
Mar 13, 2012
03/12
by
CNBC
tv
eye 245
favorite 0
quote 0
i'm seema mody.he nasdaq fueled by the strength in technology, closing for the first time above 3,000 since december of 2000. the question is, can we hold this level. and even build on 3,000 going forward. for today, some of the winners include apple. iphone 5 launch and dividend being issued are two things they're expecting this year. the sector that provided leadership, though, in today's trade, semiconductors. the index outperforming the nasdaq in hopes that pricing will recover in the latter half of 2012. the risk-on rally helping shares of first solar. this is a volatile name, going from the worst performer to the best performing stock today. how about that. >> pretty good stuff. we are waiting those stress test results from the federal reserve at 4:30 p.m. eastern time. we'll bring you that news as soon as we get it. meanwhile, we saw a big rally on wall street amid headlines out of jpmorgan, we get reaction to today's uptick in the stress test with the big name in the exchange industry. joinin
i'm seema mody.he nasdaq fueled by the strength in technology, closing for the first time above 3,000 since december of 2000. the question is, can we hold this level. and even build on 3,000 going forward. for today, some of the winners include apple. iphone 5 launch and dividend being issued are two things they're expecting this year. the sector that provided leadership, though, in today's trade, semiconductors. the index outperforming the nasdaq in hopes that pricing will recover in the...
115
115
Mar 28, 2012
03/12
by
CNBC
tv
eye 115
favorite 0
quote 0
i'm seema mody with your check on biotech stocks.akers in focus today. we all remember the big moves we saw in shares of vivus after winning the backing of the fda. the stock gained 100% in a day. but there are some bears saying tomorrow's ruling by the fda on whether additional heart safety trials are needed could add significant shares to vivus. also in focus, arena pharmaceuticals. its arrival of vivus, this stock also could nose dive. the stock down now better than 1 10%. piper jaffry downgrading that stock although the third player in the obesity drug market is orexigen. remains to be seen as a head of the gain. the stock flat right now. >> seema, thank you very much. stocks hitting new highs racking up their best first quarter since 1998. but unemployment is still high, gas prices are moving higher as well. so where does the economy and the market go from here? steve liesman joins us with the exclusive results of our cnbc all-america survey. hi, steve. >> hey, sue, thanks very much. our survey -- fascinating results inside this
i'm seema mody with your check on biotech stocks.akers in focus today. we all remember the big moves we saw in shares of vivus after winning the backing of the fda. the stock gained 100% in a day. but there are some bears saying tomorrow's ruling by the fda on whether additional heart safety trials are needed could add significant shares to vivus. also in focus, arena pharmaceuticals. its arrival of vivus, this stock also could nose dive. the stock down now better than 1 10%. piper jaffry...
128
128
Mar 16, 2012
03/12
by
CNBC
tv
eye 128
favorite 0
quote 0
seema mody joins me now at the cnbc realtime exchange. nice to be with you. you've been looking at apple stock and what it might take to get it to dare we say the number $700 a share? >> $700 a share and even $800. tyler, there are so many fascinating numbers when it comes to apple. but one really interesting comparison really jumped out at us. you can buy an ipad for less than one share of apple. we posed this question to the twitter universe. what would you buy, a share of apple or the new ipad? here are some of our favorite responses. take a look at what neal says. i would rather buy a share in apple than by the new ipad. one reason, future shares. i would rather buy a share of apple, wait until it goes up, sell and buy three ipads. what about the street? various analysts also picking one share of apple as their choice. in the last two weeks jefferies raised price target to $699. bernstein bumping to $710 and morgan stanley to $720. all targets roughly 20% higher than apple's current market price reiterating the street's confidence in apple's ability to mo
seema mody joins me now at the cnbc realtime exchange. nice to be with you. you've been looking at apple stock and what it might take to get it to dare we say the number $700 a share? >> $700 a share and even $800. tyler, there are so many fascinating numbers when it comes to apple. but one really interesting comparison really jumped out at us. you can buy an ipad for less than one share of apple. we posed this question to the twitter universe. what would you buy, a share of apple or the...
140
140
Mar 21, 2012
03/12
by
CNBC
tv
eye 140
favorite 0
quote 0
i'm seema mody here at the realtime exchange. welcome to "power lunch" where we have two out of the three, ain't that bad. the s&p after trading lower for much of the morning turning positive within the last hour right here. above 1,400. the nasdaq has been positive all day fuelled by shares of oracle and the dow creeping back well off of its lows. still down 11 points. taking our pulse of the markets, oil on the move today advancing toward yesterday's high of $108 a barrel. we also have our eye on silver. it's leading the metals higher. and we're keeping our eye out on the euro. taking a look at some of our midday movers, hartford financial getting a bump after announcing plans to sell most of life insurance realitied business. stock up 4.5%. and we previewed general mills yesterday. it's off today lowering its forecast citing higher commodity costs. stock down around .6%. and lastly, hewlett packard formally announcing its restructuring plan. we'll get you more details on that hp restructuring later on "power lunch." but for no
i'm seema mody here at the realtime exchange. welcome to "power lunch" where we have two out of the three, ain't that bad. the s&p after trading lower for much of the morning turning positive within the last hour right here. above 1,400. the nasdaq has been positive all day fuelled by shares of oracle and the dow creeping back well off of its lows. still down 11 points. taking our pulse of the markets, oil on the move today advancing toward yesterday's high of $108 a barrel. we...
105
105
Mar 26, 2012
03/12
by
CNBC
tv
eye 105
favorite 0
quote 0
i'm seema mody. here are a couple of outperformers at the nasdaq. look at e-bay up better than 2%.sing its price target saying paypal can continue to drive gold. switch to biotech. amgen ree leasing upbeat data on phase one cholesterol drug. still in trial reduces cholesterol by 66%. lastly, a small cap with big news here. arena pharmaceuticals is a competitor of vivus concerning the fda advisory panel will review their obesity drug on may 10th. investors piling into that name. >> thanks, seema lionsgate shares trading up 4.23%. julia boorstin is looking at the blockbuster movie by the numbers for us today. hi, julia. >> "the hunger games" grossed $155 million at the box office this weekend beating expectations and all sorts of records including important ones for lionsgate. already the independent studio highest grossing movie ever. and it's on track to gross about $350 million in the u.s. over the course of its run. with three more movies in the works, it's lionsgate's first ever major franchise. it will be worth as much as $1.5 billion to lionsgate. and the crowds that turned ou
i'm seema mody. here are a couple of outperformers at the nasdaq. look at e-bay up better than 2%.sing its price target saying paypal can continue to drive gold. switch to biotech. amgen ree leasing upbeat data on phase one cholesterol drug. still in trial reduces cholesterol by 66%. lastly, a small cap with big news here. arena pharmaceuticals is a competitor of vivus concerning the fda advisory panel will review their obesity drug on may 10th. investors piling into that name. >> thanks,...
201
201
Mar 19, 2012
03/12
by
CNBC
tv
eye 201
favorite 0
quote 0
i'm seema mody at the realtime exchange. and after a sluggish morning all three major indices went positive just before noon and are holding. the dow up 27 points, s&p up 7 and nasdaq up 24. taking a pulse of our markets, nat gas continues its march even higher. take a look at the 10-year note. the yield on the 10-year holding its move from last week. money flowing out of treasuries and into equities. lastly, we're keeping an eye out on the euro. to our midday movers. take a look at bank of america. one of the stocks piling the dow higher after morgan suddenly raised its price target. stock up 2%. on the flip side, sprint getting hit hard after a downgrade at bernstein research. and look at starbucks. keeping an eye on this stock. they opened its first evolution fresh juice store today. it's now up .1%. bob pisani, our man on the floor, tracking all of the action on the market. how's it looking down there? >> well, it's looking pretty good. now, remember something. we're less concerned about europe. europe is not smacking ar
i'm seema mody at the realtime exchange. and after a sluggish morning all three major indices went positive just before noon and are holding. the dow up 27 points, s&p up 7 and nasdaq up 24. taking a pulse of our markets, nat gas continues its march even higher. take a look at the 10-year note. the yield on the 10-year holding its move from last week. money flowing out of treasuries and into equities. lastly, we're keeping an eye out on the euro. to our midday movers. take a look at bank of...
110
110
Mar 22, 2012
03/12
by
CNBC
tv
eye 110
favorite 0
quote 0
i'm seema mody. hard disk driver makers on the rise. western digital getting upgraded by needham. and also bullish comments around seagate, the best performer on nasdaq 100. wattson pharma reports close to buying for close to $7 million. up for a second straight day. this could be a transformative deal if they do close. lastly, a look at tivo, dismissing patent litigation with microsoft. the market always liking clarity. that stock up better than 1%. tyler, back to you. >> seema, thank you very much. the dow and s&p on track now for their worst weekly declines of the year so far. renewed worries on the eurozone and a slowdown in china overpowering positive news that u.s. jobless claims hit a four-year low. now, after a bull run over the past few months, have investors missed their opportunity to jump in just a day after goldman sachs says it's the best opportunity of a lifetime? joining us is chief investment strategist with raymond james. and destination wealth management ceo and a cnbc contributor. so which is it, jeff? the best time in a generation to get? or a time when the be
i'm seema mody. hard disk driver makers on the rise. western digital getting upgraded by needham. and also bullish comments around seagate, the best performer on nasdaq 100. wattson pharma reports close to buying for close to $7 million. up for a second straight day. this could be a transformative deal if they do close. lastly, a look at tivo, dismissing patent litigation with microsoft. the market always liking clarity. that stock up better than 1%. tyler, back to you. >> seema, thank...
146
146
Mar 2, 2012
03/12
by
CNBC
tv
eye 146
favorite 0
quote 0
seema mody here at the nasdaq. want to bring your attention to shares of zynga trimming their gains after hitting an all-time high this morning. we had all things digital reporting that their lead game designer, michael mccormick, may be stepping down. that's the news on zynga. also look at shutterfly. the stock up better than 19%. also take a look at flex tronic. looking to sell for around $23 million. nonetheless the stock up 2%. tyler and sue, back over to you. >> thank you very much, seema. it's time now to buy, sell or hold. our end of the week roundup of the biggest stock stories making headlines this week. and we have one of our "fast money" guys. let's start with wells. there was news about wells, a lot of buzz, warren buffett said it was one of his favorite financials. what do you do? >> he's talking his own book, which is a great thing to do. we all do it. with wells i would buy it. i think it's a very cheap stock, however, i like jpmorgan better. there's nothing wrong with wells. jpmorgan is more aggress
seema mody here at the nasdaq. want to bring your attention to shares of zynga trimming their gains after hitting an all-time high this morning. we had all things digital reporting that their lead game designer, michael mccormick, may be stepping down. that's the news on zynga. also look at shutterfly. the stock up better than 19%. also take a look at flex tronic. looking to sell for around $23 million. nonetheless the stock up 2%. tyler and sue, back over to you. >> thank you very much,...
262
262
Mar 2, 2012
03/12
by
CNBC
tv
eye 262
favorite 0
quote 0
seema mody back in new york. the jobs picture might not be as bad as we think. the week is with us. >> hi, carl, it's not all good news, i'm sorry to say. the good news is i guess maybe we can believe the unemployment rate. let me explain. a lot of people have been worried that the drop has more to do with people leaving the labor force. well, barclays capital among the latest of firms saying the stronger trend is demographics. a lot of people are retiring. in fact, this is what's driving down the employment population ratio. there's focus on this. ben bernanke among others talking about how it might be a truer read. what we have seen is a decline from mid decade levels, down to levels of about 64, under 64%. that bit may not sound like a big deal, but if the employment population ratio -- we could see it as high as 12%. so maybe you can believe this rate, maybe it's not about to leap back up, but the problem, though, carl, is this means everything from our po templeal growth rate to factors affecting income across the economy are significantly lower. it's a pro
seema mody back in new york. the jobs picture might not be as bad as we think. the week is with us. >> hi, carl, it's not all good news, i'm sorry to say. the good news is i guess maybe we can believe the unemployment rate. let me explain. a lot of people have been worried that the drop has more to do with people leaving the labor force. well, barclays capital among the latest of firms saying the stronger trend is demographics. a lot of people are retiring. in fact, this is what's driving...